Open Access · CC BY 4.0
mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer
EXCLI Journal · 28.05.2025 · 24 · 570-572
DOI: 10.17179/excli2025-8327 ↗Kurz gefasst
Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 28.05.2025. Verfasst von Mudasir Maqbool und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Maqbool, M., Qadrie, Z., Rana, A. J., Ashique, S., & Hussain, M. S. (2025). mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer. EXCLI Journal, 24, 570-572. https://doi.org/10.17179/excli2025-8327
Vancouver
Maqbool M, Qadrie Z, Rana AJ, Ashique S, Hussain MS. mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer. EXCLI Journal. 2025;24:570-572. doi:10.17179/excli2025-8327
BibTeX
@article{Maqbool2025,
author = {Maqbool, Mudasir and Qadrie, Zulfkar and Rana, Amita Joshi and Ashique, Sumel and Hussain, Md Sadique},
title = {mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {570--572},
doi = {10.17179/excli2025-8327}
}
EUVIMED